Actively Recruiting

Phase 4
Age: 18Years +
All Genders
NCT06562738

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

Led by The Third People's Hospital of Chengdu · Updated on 2024-08-20

55

Participants Needed

1

Research Sites

43 weeks

Total Duration

On this page

Sponsors

T

The Third People's Hospital of Chengdu

Lead Sponsor

A

Affiliated Hospital of North Sichuan Medical College

Collaborating Sponsor

AI-Summary

What this Trial Is About

This is an investigator-initiated, single-arm, prospective clinical study to evaluate the efficacy and safety of heptapopal in the treatment of thrombocytopenia prior to elective surgery

CONDITIONS

Official Title

Clinical Study on Efficacy and Safety of Hetrombopag in the Preoperative Patients of Thrombocytopenia

Who Can Participate

Age: 18Years +
All Genders

Eligibility Criteria

Eligible

You may qualify if you...

  • Adults 18 years old or older with a diagnosis of immune thrombocytopenia
  • Platelet count of 75×10^9/L or lower before scheduled elective surgery
Not Eligible

You will not qualify if you...

  • History of allergy to Thrombopoietin Receptor Agonists (TPO-RA) drugs
  • Severe bleeding symptoms such as gastrointestinal, important organ, or intracranial bleeding
  • Thrombotic diseases including pulmonary embolism, arterial thrombosis, or disseminated intravascular coagulation
  • Positive for HIV antibody or anti-treponema pallidum specific antibody
  • New York Heart Association Grade 3 or 4 congestive heart failure
  • History of angina, heart attack, or stroke within 6 months before screening
  • Active infection that is difficult to control
  • Pregnant or lactating women
  • Any other condition deemed unsuitable by the investigator

AI-Screening

AI-Powered Screening

Complete this quick 3-step screening to check your eligibility

1
2
3
+1

Trial Site Locations

Total: 1 location

1

Chengdu Third People's Hospital

Chengdu, Sichuan, China, 610000

Actively Recruiting

Loading map...

Research Team

Y

Ying Li, PhD

CONTACT

Z

Zuofeng Liu, Master

CONTACT

How is the study designed?

Study Type

INTERVENTIONAL

Masking

NONE

Allocation

NA

Model

SINGLE_GROUP

Primary Purpose

TREATMENT

Number of Arms

1

Not the Right Trial for You?

Explore thousands of other clinical trials that might be a better match.
Sign up to get personalized trial recommendations delivered to your inbox.

Already have an account? Log in here